Amphastar Pharmaceuticals AMPH Accrued Income Taxes, Current
Accrued Income Taxes, Current at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's accrued income taxes, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's accrued income taxes, current?
- Amphastar Pharmaceuticals (AMPH) reported accrued income taxes, current of $414K in Q1 2026.
- How has Amphastar Pharmaceuticals's accrued income taxes, current changed year-over-year?
- Amphastar Pharmaceuticals's accrued income taxes, current decreased by 97.3% year-over-year, from $15.14M to $414K.
- What is the long-term trend for Amphastar Pharmaceuticals's accrued income taxes, current?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's accrued income taxes, current has grown at a -26.0% compound annual growth rate (CAGR), from $1.08M to $239K.
- What does accrued income taxes, current mean?
- This represents the estimated amount of income tax payable to government authorities for the current period. It reflects the company's tax liability based on taxable income generated during the year, which is due within the next twelve months. It is a key indicator of the company's immediate tax obligations.